Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery
暂无分享,去创建一个
Leslie Z. Benet | L. Benet | M. Hebert | Mary F. Hebert | Chi‐Yuan Wu | Chi Yuan Wu | Vincent J. Wacher | V. Wacher
[1] L. Benet,et al. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy , 1995, Molecular carcinogenesis.
[2] J. Kolars,et al. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. , 1992, The Journal of clinical investigation.
[3] J. Kolars,et al. First-pass metabolism of cyclosporin by the gut , 1991, The Lancet.
[4] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Watkins,et al. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. , 1987, The Journal of clinical investigation.
[6] L. Benet,et al. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction , 1992, Clinical pharmacology and therapeutics.
[7] M Rowland,et al. Differentiation of absorption and first‐pass gut and hepatic metabolism in humans: Studies with cyclosporine , 1995, Clinical pharmacology and therapeutics.
[8] Y. Tam. Individual Variation in First-Pass Metabolism , 1993, Clinical pharmacokinetics.
[9] L. Benet,et al. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine , 1995, Clinical pharmacology and therapeutics.
[10] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .